SCHEMBL6779751

SCHEMBL6779751

CCOC(=O)NC(=N)c1cccc(C(=O)c2cccc(N)c2NC(=O)c2ccc(OC)cc2)c1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 5/20 0.44
GAA P10253 2/20 0.44
CYP2C9 P11712 2/20 0.44
CYP1A2 P05177 1/20 0.44
HPGD P15428 1/20 0.44
CYP2C19 P33261 1/20 0.44
HDAC1 Q13547 3/20 0.43
HDAC3 O15379 2/20 0.43
HDAC2 Q92769 2/20 0.43
HDAC4 P56524 1/20 0.43
HDAC7 Q8WUI4 1/20 0.43
HDAC10 Q969S8 1/20 0.43
HDAC11 Q96DB2 1/20 0.43
HDAC8 Q9BY41 1/20 0.43
HDAC6 Q9UBN7 1/20 0.43
HDAC9 Q9UKV0 1/20 0.43
HDAC5 Q9UQL6 1/20 0.43
KCNK3 O14649 1/20 0.42
SMN1; SMN2 Q16637 3/20 0.42
RAB9A P51151 3/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6770990 0.87 HDAC1 (0.43) ALDH1A1CYP2C9HDAC1HDAC3HDAC2
Hydrochloric Acid SCHEMBL6541779 0.83 HDAC1 (0.49) ALDH1A1CYP2C9HDAC1HDAC3HDAC2
SCHEMBL6779755 0.81 MAPT (0.48) ALDH1A1HPGDSMN1; SMN2RAB9ANPC1
SCHEMBL5226432 0.80 HDAC1 (0.53) ALDH1A1GAACYP2C9CYP1A2CYP2C19
SCHEMBL5224278 0.79 NPC1 (0.58) ALDH1A1CYP2C9CYP1A2HPGDHDAC1
SCHEMBL6771915 0.79 PLAU (0.52) ALDH1A1CYP1A2HPGDSMN1; SMN2RAB9A
SCHEMBL7246022 0.78 HDAC1 (0.59) ALDH1A1CYP2C9HDAC1HDAC3HDAC2
SCHEMBL7053464 0.78 HDAC1 (0.48) ALDH1A1GAACYP2C9CYP1A2CYP2C19
SCHEMBL7244781 0.77 CYP2C9 (0.56) ALDH1A1GAACYP2C9HPGDHDAC1
Hydrochloric Acid SCHEMBL6778471 0.77 HDAC1 (0.52) ALDH1A1CYP2C9HDAC1HDAC3HDAC2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6677369-B2 CARBOXIMIDAMIDE DERIVATIVE ANTICOAGULANTS INHIBIT FACTOR XA ELI LILLY AND COMPANY 2004-01-13 US disclosed
US-20030195223-A1 An anticoagulant, blood inhibitor of factor Xa, a N1-amidinebenzoyl- N2-benzoyl-1,2-benzenediamine derivatives; chemical intermediates BEIGHT DOUGLAS WADE (US) 2003-10-16 US disclosed
US-6417200-B1 BLOOD COAGULATION FACTOR XA IN MAMMALS ELI LILLY AND COMPANY 2002-07-09 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030195223-A1 An anticoagulant, blood inhibitor of factor Xa, a N1-amidinebenzoyl- N2-benzoyl-1,2-benzenediamine derivatives; chemical intermediates F12, F11, F2 ALDH1A1 1095/4885GAA 1277/4885CYP2C9 78/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.